TABLE 2.

Effect of the Mobile Phone Intervention on Primary and Secondary Outcomes at 2 Weeks and 4 Months Follow-Up

OutcomeIntervention Arm n/N (%)Control Arm n/N (%)P Value (χ2)Unadjusted OR (95% CI)Adjusted OR (95% CI)a
Primary outcomes
LARC use at 4 months48/389 (12%)59/383 (15%).220.77 (0.51, 1.17)1.06 (0.53, 2.13)b
LARC use with MI at 4 months (100 imputations)55/484 (11%)72/478 (15%).110.73 (0.49, 1.08)0.95 (0.49, 1.83)c
Secondary outcomes
4-month follow-up
Effective modern method use (any method)d214/389 (55%)204/383 (53%).631.07 (0.81, 1.42)1.04 (0.75, 1.43)b
Subsequent pregnancy6/389 (2%)10/383 (3%).300.58 (0.21, 1.62)0.48 (0.16, 1.43)e
Subsequent MR or abortion2/389 (<1%)4/383 (1%).400.49 (0.09, 2.69)0.43 (0.08, 2.41)e
2-week follow-up
LARC use48/413 (12%)56/411 (14%).390.83 (0.55, 1.26)1.57 (0.68, 3.62)b
Effective modern method use223/413 (54%)221/411 (54%).951.01 (0.77, 1.33)1.07 (0.74, 1.54)b
4-month contraceptive calendar (log rank test)Discontinuations/time at risk (weeks)Discontinuations/time at risk (weeks)Log rank test
LARC discontinuation2/661 (<1%)2/844 (<1%).81
Injectable discontinuation20/620 (3%)14/517 (<3%).56
Pill discontinuation27/1693 (2%)32/1555 (2%).33
Adverse outcomes at 4 months
Physical IPV42/386 (11%)25/382 (7%).031.74 (1.04, 2.92)1.97 (1.12, 3.46)b
Physical IPV with MI (100 imputations)f57/484 (12%)31/478 (6%).031.87 (1.07, 3.27)2.16 (1.16, 4.02)c
Sexual IPV47/386 (12%)36/379 (10%).231.32 (0.83, 2.09)1.25 (0.78, 2.02)b
Physical violence from in-laws6/384 (2%)4/380 (1%).541.49 (0.42, 5.33)1.20 (0.31, 4.62)b
Anything happened to them as a result of being in the study
Nothing335/385 (92%)366/381 (96%).06
Something good28/385 (7%)13/381 (3%)2.22 (1.13, 4.36)2.25 (1.14, 4.44)g
Something bad2/385 (<1%)2/381 (<1%)1.03 (0.14, 7.36)2.10 (0.19, 3.60)g
  • Abbreviations: CI, confidence interval; IPV, intimate partner violence; IUD, intrauterine device; LARC, long-acting reversible contraception; MI, multiple imputation; MR, menstrual regulation; OR, odds ratio; PPI, Poverty Probability Index; SES, socioeconomic status.

  • a Total number varies due to missing data on baseline covariates included in the model (see Table 1).

  • b Adjusted for baseline use of these methods/experience of this outcome, age, and SES (PPI Score).

  • c Adjusted for baseline use/experience only.

  • d Pill, injection, implant, IUD, or sterilization. At 4 months, participants were asked about how regularly they take the pill and were only classified as pill users if they reported always or usually taking it on time.

  • e Adjusted for baseline LARC use, age, and SES (PPI score).

  • f Analysis not specified in study protocol.

  • g Adjusted for age and SES (PPI score).